Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Piramal Pharma Limited ( (IN:PPLPHARMA) ).
Piramal Pharma Limited has announced that its shareholders have approved, via remote e-voting through a postal ballot, the appointment of Amit Soni as an Independent Director of the company by way of a special resolution. The resolution, deemed passed on 16 January 2026, reflects shareholder support for strengthening the company’s board structure and governance framework, and the voting results along with the scrutinizer’s report have been made available on both the company’s and the e-voting service provider’s websites for investor transparency.
More about Piramal Pharma Limited
Piramal Pharma Limited is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of a broad range of pharma products and services. The company operates across domestic and international markets, serving the healthcare and life sciences sectors through formulations, complex generics, contract development and manufacturing, and related pharmaceutical solutions.
Average Trading Volume: 235,307
Technical Sentiment Signal: Sell
Current Market Cap: 223.4B INR
Learn more about PPLPHARMA stock on TipRanks’ Stock Analysis page.